20094 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
Cannabinoid Powder With High Specific Surface Area
#2EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE AND AMITRIPTYLINE HYDROCHLORIDE
#3PROCESS FOR PREPARING HIGH-DENSITY COENZYME Q10 PARTICLES
#4AN ORODISPERSIBLE TABLET OF RIVAROXABAN
#5Spray-dried blood products and methods of making same
#6SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#7SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#8Taxane Particles and Their Use
#9Injectable Suspensions
#10Formulations And Methods For Contemporaneous Stabilization Of Active Proteins During Spray Drying And Storage
#11Synthetic progestogens and pharmaceutical compositions comprising the same
#12Amorphous Photosensitizing Particles, Methods For The Preparation Thereof, And Methods For The Use Thereof
#13PLANT ESSENTIAL OIL AMINO ACID COMPOSITION AND PREPARATION METHOD THEREFOR
#14COLLAGEN POWDER, PROCESS FOR ITS PREPARATION AND USES THEREOF
#15EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE AND AMITRIPTYLINE HYDROCHLORIDE
#16METHOD FOR GENERATING DRY POWDER SUITABLE FOR INHALATION ADMINISTRATION OF ANTIMICROBIAL PHOSPHOLIPID COMPOSITIONS
#17KAVA COMPOSITIONS AND METHODS OF USE
#18Pharmaceutical Complex for Radioprotection, Preparation Method, and Applications thereof
#19Application Method of Radix Paeoniae Alba and Dendrobium Officinale for Preparing Drug for Treatment of Hypertension
#20Glucocorticoid Particles and Their Use
#21DELIVERY OF ACTIVE AGENTS
#22CREATINE COMPOSITION AND METHODS OF USING SAME
#23METHODS AND SYSTEMS FOR USE OF LOW-VOLATILITY SOLVENTS FOR SPRAY DRYING
#24TOPICAL TREATMENT FOR ANIMALS
#25GRANULATION OF TOPINAMBUR
#26Inhaled PDE-V Inhibitor Drugs
#27Synthetic progestogens and pharmaceutical compositions comprising the same
#28Treatment of epithelial cysts by intracystic injection of antineoplastic particles
#29FERMENTED AVOCADO GRANULATE AND FOOD SUPPLEMENTS CONTAINING IT
#30Sorafenib particles and uses thereof
#31KAVA COMPOSITIONS AND METHODS OF USE
#32METHOD FOR PREPARING SOLID FORMULATION OF PIMAVANSERIN
#33Fast Release Benzoic Acid In Feed
#34DIETARY SUPPLEMENT COMPOSITIONS COMPRISING GANODERMA AND METHODS FOR MAKING
#35WHOLE CANNABIS PRODUCT COMPOSITIONS AND METHODS OF MANUFACTURE WITHOUT SPECIFIC DECARBOXYLATION OF THE WHOLE PLANT CONSTITUENTS
#36KAVA COMPOSITIONS AND METHODS OF MAKING SAME
#37POWDERED FORMULATIONS OF CROMOLYN SODIUM AND IBUPROFEN
#38PARTICLE SIZE CONTROL
#39CANNABIDIOL NANODRUG FORMULATIONS AND METHODS FOR USE OF THE SAME
#40Niraparib particles and uses thereof
#41Rucaparib particles and uses thereof
#42Treatment of epithelial cysts by intracystic injection of antineoplastic particles
#43DRUG SUBSTANCE OF LEMBOREXANT AND MEDICINAL COMPOSITION COMPRISING SAME
#44NANO-SEEDING
#45Biodegradable Implant Including Naltrexone
#46Synthetic progestogens and pharmaceutical compositions comprising the same
#47PROCESS FOR THE PREPARATION OF A NANOPARTICULATE ACTIVE INGREDIENT
#48Process for spray drying a GLP-1 peptide
#49Delivery of Active Agents
#50Synthetic progestogens and pharmaceutical compositions comprising the same
#51Synthetic progestogens and pharmaceutical compositions comprising the same
#52MICROVASCULAR BLOOD FLOW DECREASING AGENT AND USE THEREOF
#53CONTINUOUS CRYSTALLIZATION OF CANNABINOIDS IN A TUBULAR FLOW REACTOR
#54Sorafenib particles and uses thereof
#55Synthetic progestogens and pharmaceutical compositions comprising the same
#56Synthetic progestogens and pharmaceutical compositions comprising the same
#57Reduction of flake-like aggregation in nanoparticulate active agent compositions
#58Formulations of pimavanserin
#59Synthetic progestogens and pharmaceutical compositions comprising the same
#60PHARMACEUTICAL COMPOSITION COMPRISING SPHERICAL AGGLOMERATES OF TIMAPIPRANT
#61PROCESS FOR PREPARING SPHERICAL AGGLOMERATES OF TIMAPIPRANT
#62Synthetic progestogens and pharmaceutical compositions comprising the same
#63Manganese Ferrite Nanoparticles for Use as MRI Contrast Agents and Magnetohypothermia Agents
#64Spray-Dried Blood Products and Methods of Making Same
#65Edds chelated nanoceria with catalase-like activity
#66Composition and method for treating humans using low-fodmap diets
#67Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor
#68Synthetic progestogens and pharmaceutical compositions comprising the same
#69Gel-inducible composition for pet administration assistance
#70Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storage
#71Taxane Particles and Their Use
#72METHOD FOR PREPARING AND DELIVERING BISANTRENE FORMULATIONS
#73PHARMACEUTICAL COMPOSITIONS OF RIBAVIRIN
#74Synthetic progestogens and pharmaceutical compositions comprising the same
#75Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storage
#76FAST RELEASE BENZOIC ACID IN FEED
#77FORMULATIONS OF PIMAVANSERIN
#78Fine nano-sized medicinal agent and use thereof
#79Treatment of epithelial cysts by intracystic injection of antineoplastic particles
#80Antibiotic compositions for treating bacterial infections
#81Synthetic progestogens and pharmaceutical compositions comprising the same
#82CRYOPROTECTIVE AGENTS FOR PARTICULATE FORMULATIONS
#83Topical treatment for animals
#84METHODS OF SIZING 6B,7B:15B,16B-DIMETHYLENE-3-OXO-17A-PREGN-4-ENE-21,17-CARBOLACTONE PARTICLES AND COMPOSITIONS COMPRISING THE SAME
#85Low temperature spray drying of carrier-free compositions
#86Injectable Suspensions
#87Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#88FORMULATIONS OF PIMAVANSERIN
#89Spray drying process with continuous preparation of spray solution
#90METHOD AND APPARATUS
#91Organosilicon compound microparticles and process for their preparation
#92Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#93Novel Form of Invermectin and a Process for Making it
#94POWDERED FORMULATIONS OF CROMOLYN SODIUM AND IBUPROFEN
#95Taxane particles and their use
#96METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS
#97Taxane Particles and Their Use
#98EDDS CHELATED NANOCERIA WITH CATALASE-LIKE ACTIVITY
#99Solid Pharmaceutical Compositions for Treating HCV
#100Processes for the preparation of uracil derivatives
#101Glucocorticoid “nintedanib” particles and their use
#102Low temperature spray drying of carrier-free compositions
#103Inhaler article with occluded airflow element
#104Taxane particles and their use
#105FORMULATION COMPRISING GLYCOPYRROLATE, METHOD AND APPARATUS
#106DELIVERY OF ACTIVE AGENTS
#107TENOFOVIR GRANULES
#108Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor
#109Taxane particles and their use
#110Rehydration of micronized tecovirimat monohydrate
#111Particulate materials
#112Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof
#113Low temperature spray drying of carrier-free compositions
#114Co-spray drying of meropenem and colistin and the uses thereof
#115Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#116PHARMACEUTICAL COMPOSITIONS
#117Solid Pharmaceutical Compositions for Treating HCV
#118Tobacco products
#119Microvascular blood flow decreasing agent and use thereof
#120Method of preparing a pharmaceutical composition
#121Delivery of Active Agents
#122GRANULES
#123Use of homoeriodictyol (HED) for reducing the gastric acid secretion-stimulating effect of n-acetyl-4-aminophenol (Paracetamol)
#124Thrombin microcapsules, preparation and uses thereof
#125Powder formulation having hypoglycemic and hypolipidemic functions and method for preparing the same
#126Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#127Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#128Process of preparing active pharmaceutical ingredient salts
#129Processes for the preparation of uracil derivatives
#130Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#131Method for preparing granules or pills containing extracts in high concentration
#132EDDS chelated nanoceria with catalase-like activity
#133Macrolide particulates, methods for preparation, and medical devices associated therewith
#134Reduction of flake-like aggregation in nanoparticulate active agent compositions
#135Solid soluble ferric pyrophosphate formulations, kits, and methods using the same
#136ACOUSTIC MIXING FOR AUTO GRANULATION
#137Equipment Assembly for and Method of Processing Particles
#138Tenofovir granules
#139NON-MECHANICAL PROCESS FOR THE MICRONIZATION OF DIGOXIN
#140Taxane particles and their use
#141Methods and products for treating and/or delaying onset of dysplastic lesions
#142Spray-dried blood products and methods of making same
#143Nozzle assembly and methods for use
#144Collection device and methods for use
#145Dry powder formulation of azole derivative for inhalation
#146Wafer and capsule formulations with enhanced dissolution rates for fenofibrate
#147Method of making particles for use in a pharmaceutical composition
#148Non-bleeding bioactive natural pigments which prevent color and dust explosions, method of preparation thereof
#149Formulation, preparation method and use of Chinese herbal medicine composition for soothing liver
#150Preparation method of albumin peptide combination having the action of inhibiting the proliferation of cancer cells
#151Traditional Chinese medicine combination for regulating immune function and preparation method therefor
#152Chemoembolization composition comprising anti-angiogenic agents
#153Particulate materials
#154Method of forming silver nanoparticles and a use thereof
#155Antibiotic compositions for treating bacterial infections
#156Processes for producing protein microparticles
#157FORMULATION FOR ORAL ADMINISTRATION CONTAINING MESALAZINE
#158Nanoparticles, method of preparing the same and their use
#159Process for the production of particles
#160ORAL SOLID PREPARATION COMPRISING ARIPIPRAZOLE AND METHOD FOR PRODUCING ORAL SOLID PREPARATION COMPRISING ARIPIPRAZOLE
#161COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS
#162Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storage
#163Compositions and methods for atmospheric spray freeze drying
#164Method for manufacturing aloe extract, and aloe extract
#165Acoustic mixing for auto granulation
#166Solid Pharmaceutical Compositions for Treating HCV
#167Macrolide particulates, methods for preparation, and medical devices associated therewith
#168Taxane particles and their use
#169Pediatric oral suspension formulations of amoxicillin and clavulanate potassium and method for using same
#170Particulate materials
#171Method of manufacturing and purifying prothrombin complex concentrate from Fraction III for intravenous injection and a method of curing and preventing Hemophilia A with inhibitors or Hemophilia B in patients infected with HIV-1 and HIV-2
#172Particle size reduction of an antimuscarinic compound
#173METHOD FOR ENLARGING THE PARTICLE SIZE OF CRYSTALLINE MICROPARTICLES OF ACTIVE SUBSTANCE
#174Heteroaryl compounds as BTK inhibitors and uses thereof
#175Method Of Making Particles For Use In A Pharmaceutical Composition
#176Rehydration of micronized tecovirmimat monohydrate
#177Reduction of flake-like aggregation in nanoparticulate active agent compositions
#178Reduction of flake-like aggregation in nanoparticulate active agent compositions
#179Synthesis and Particle Engineering of Cocrystals
#180Reduction of flake-like aggregation in nanoparticulate active agent compositions
#181PHARMACEUTICAL COMPOSITION OF SODIUM PICOSULFATE
#182PHARMACEUTICAL COMPOSITIONS
#183Apparatus and method for producing biobased carriers from byproducts of biomass processing
#184Swallowable N-acetylcysteine tablets
#185Method of preparing drug agglomerate
#186Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storage
#187Methods and systems for multi-stage drying of plasma
#188Compositions of glycopyrronium salt for inhalation
#189Drug Particles From Freezing Onto A Surface
#190Compositions and methods for imaging and treatment
#191Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#192Preparation of coffee-based extracts and powders
#193Method for preparing pharmaceutical compositions of rhizomes from or having a high content of 1′S-1′-acetoxychavicol acetate (ACA)
#194STABLE DOSAGE FORMS OF IMATINIB MESYLATE
#195Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions
#196Equipment assembly for and method of processing particles
#197Dynamic suspension drying (DSD) to control Ostwald Ripening
#198Injectable depot formulation comprising optically active tolvaptan and process of producing the same
#199Traditional Chinese medicine combination for regulating immune function and preparation method therefor
#200Process for producing solid particles
#201Magnetic iron oxide fine particles, and magnetic particle-containing water dispersion and process for producing the same
#202Nanoclusters compositions and methods
#203Method for preparing granules or pills containing extracts in high concentration
#204AGGREGATE NANOPARTICULATE MEDICAMENT FORMULATIONS, MANUFACTURE AND USE THEREOF
#205Formulation and manufacturing process for calcium acetate capsules
#206Porous carbon particles for use in the treatment or prevention of liver disease
#207NICOTINAMIDE POWDER AND PROCESS AND DEVICE FOR ITS PRODUCTION
#208DRY POWDER FORMULATION OF AZOLE DERIVATIVE FOR INHALATION
#209Wafer and capsule formulations with enhanced dissolution rates for fenofibrate
#210Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
#211Particle size reduction of an antimuscarinic compound
#212Processes for producing protein microparticles
#213Nano-suspension process
#214Pharmaceutical compositions
#215Stable colloidal gold nanoparticles with controllable surface modification and functionalization
#216Solid naproxen concentrates and related dosage forms
#217Particulate materials
#218Method for production of particles of pharmaceutical substances and the use thereof
#219Method for production of particles of pharmaceutical substances and the use thereof
#220Formulation and manufacturing process for calcium acetate capsules
#221Chemoembolization composition comprising anti-angiogenic agents
#222Medical devices and methods including polymers having biologically active agents therein
#223Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
#224Alloplastic injectable dermal filler and methods of use thereof
#225SOLID NAPROXEN CONCENTRATES AND RELATED DOSAGE FORMS
#226Method for producing crystalline active ingredient particles
#227Compositions for reduction of side effects
#228METHODS FOR FREEZING AND THAWING PROTEINS
#229Imatinib mesylate oral pharmaceutical composition and process for preparation thereof
#230Ingredients for inhalation and methods for making the same
#231Barrier composition
#232Spherical Protein Particles and Methods of Making and Using Them
#233ANTISOLVENT SOLIDIFICATION PROCESS
#234Bioequivalent formulation of efavirenz
#235Stable colloidal gold nanoparticles with controllable surface modification and functionalization
#236Method for producing pancreatin pellets
#237Calcium sulfate composite particles including aggregated calcium sulfate nanoparticles and method of use for bone augmentation
#238Vaccine formulations and uses thereof
#239Compositions and methods for delivery of frozen particle adhesives
#240Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
#241COMPLEXATION OF METAL IONS WITH POLYPEPTIDES
#242Tolbutamide Particle And Preparing Method Thereof And Method Of Reducing A Blood Glucose
#243Compositions and methods for biological remodeling with frozen particle compositions
#244Compositions and methods for biological remodeling with frozen particle compositions
#245Nano- and Micro- Encapsulation of Biomaterials Into Particles and Capsules by Varying Precipitation Conditions
#246METHOD AND KIT FOR TOPICAL ELIMINATION OF PSORIATIC LESIONS WITH A CAUSTIC APPLICATOR
#247Synthesis of small particles
#248Method and composition for treating migraines
#249Submicron Particles of Antineoplastic Agents
#250COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION
#251Burdock fruit extract containing arctigenin at high content and process for producing same
#252Spray-dried blood products and methods of making same
#253Method for obtaining solid micro- or nanoparticles
#254Formulation Comprising Bioactive Agents And Method Of Using Same
#255PREPARATION FOR VAGINAL AND RECTAL USE AND RELATIVE PRODUCTION METHOD
#256SOLID CALCIUM LACTATE IN SUBSTANTIALLY SPHERICAL FORM
#257Polyvinyl formamide (PNVF) and polyvinyl amine (PVAm)nanoparticles, nanocapsules and nanogels
#258Apo-2 ligand/trail formulations
#259ANTISOLVENT SOLIDIFICATION PROCESS
#260Nanocluster compositions and methods
#261Doxycycline metal complex in a solid dosage form
#262Methods for micronization of hydrophobic drugs
#263AMPHIPHILIC PROTEINS AS MORPHOLOGY MODIFIERS
#264Frozen compositions and methods for piercing a substrate
#265Pharmaceutical Compositions of Atorvastatin
#266Process for making micro-sized protein particles
#267Fermented plant extracts, methods of production and uses
#268Porous drug matrices and methods of manufacture thereof
#269ABSORBENT POLYMERIC COMPOSITIONS WITH VARYING COUNTERION CONTENT AND THEIR METHODS OF PREPARATION AND USE
#270RASAGILINE MESYLATE PARTICLES AND PROCESS FOR THE PREPARATION THEREOF
#271Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
#272POLYMERIC COMPOSITIONS WITH ENHANCED SALINE HOLDING CAPACITY AND THEIR METHOD OF PREPARATION AND USE
#273Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
#274Processes for the preparation of uracil derivatives
#275POLYMERIC COMPOSITIONS AND THEIR METHOD OF USE IN COMBINATION WITH ACTIVE AGENTS
#276Method of crystallization
#277NANOPARTICLE FORMATION VIA RAPID PRECIPITATION
#278SOLID NAPROXEN CONCENTRATES AND RELATED DOSAGE FORMS
#279Device, method and use for the formation of small particles
#280VITAMIN K3 DERIVATIVE / NSA FORMULATION
#281AGGLOMERATES BY CRYSTALLISATION
#282Compositions containing resveratrol and pectin
#283Ultrafine zinc oxide particle dispersion solution, method for producing the ultrafine zinc oxide particle dispersion solution, and zinc oxide thin film
#284Intranasal pharmaceutical compositions with improved pharmacokinetics
#285CONTROLLED RELEASE FORMULATIONS
#286AMORPHOUS ARFORMOTEROL L-(+)-TARTRATE
#287GRANULES COMPRISING A BETA-LACTAM ANTIBIOTIC
#288Method for producing biologically ingestible microparticles, biologically ingestible microparticles, and dispersion and pharmaceutical composition containing the same
#289Alloplastic injectable dermal filler and methods of use thereof
#290REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE ACTIVE AGENT COMPOSITIONS
#291Method and arrangement for the production of particles
#292Process and arrangement for producing particles utilizing subcritical fluids
#293SUPERCRITICAL FLUID FACILITATED PARTICLE FORMATION IN MICROFLUIDIC SYSTEMS
#294COMPOSITIONS FOR TREATING PARKINSON'S DISEASE
#295Method of making particles for use in a pharmaceutical composition
#296Synthesis of small particles
#297METHOD FOR PREPARATION OF PARTICLES
#298Process for obtaining steroidal phosphate compounds
#299Method of Producing Porous Microparticles
#300Method for Manufacturing a Pharmaceutical Form of Oseltamivir Phosphate